Utilized for infected eczema to manage bacterial population and support inflammation reduction.
Mechanism of Action
Fusidic acid inhibits bacterial protein synthesis, providing antimicrobial activity against common skin pathogens. Betamethasone suppresses the localized immune response, alleviating the swelling and itching associated with the skin condition.
Route of Administration
Topical
Onset Time
1–3 days
Duration
12–24 hours
Contraindications
Primary skin infections caused by virus or fungi, Hypersensitivity to any component, Rosacea
Severe Adverse Events
Adrenal suppression, Severe contact dermatitis, Anaphylaxis — requires immediate medical attention
Common Side Effects
Stinging, Burning, Itching
Uncommon Side Effects
Skin thinning, Rash, Erythema
Drug Interactions
Alcohol
Pregnancy Safety Warnings
FDA Category C: Use with caution. Breastfeeding: Compatible with caution; avoid breast application.
Age Restrictions
Safety and efficacy established in pediatric patients; use shortest duration possible.
Information related to Betamethasone with Fusidic Acid is compiled and periodically reviewed with reference to established medical sources and prescribing guidance. Content is provided for general reference and should be confirmed with a registered healthcare professional before use.
